288 related articles for article (PubMed ID: 8053614)
1. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
Barst RJ; Rubin LJ; McGoon MD; Caldwell EJ; Long WA; Levy PS
Ann Intern Med; 1994 Sep; 121(6):409-15. PubMed ID: 8053614
[TBL] [Abstract][Full Text] [Related]
2. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
Barst RJ; Rubin LJ; Long WA; McGoon MD; Rich S; Badesch DB; Groves BM; Tapson VF; Bourge RC; Brundage BH; Koerner SK; Langleben D; Keller CA; Murali S; Uretsky BF; Clayton LM; Jöbsis MM; Blackburn SD; Shortino D; Crow JW;
N Engl J Med; 1996 Feb; 334(5):296-301. PubMed ID: 8532025
[TBL] [Abstract][Full Text] [Related]
3. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
Rubin LJ; Mendoza J; Hood M; McGoon M; Barst R; Williams WB; Diehl JH; Crow J; Long W
Ann Intern Med; 1990 Apr; 112(7):485-91. PubMed ID: 2107780
[TBL] [Abstract][Full Text] [Related]
4. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Badesch DB; Tapson VF; McGoon MD; Brundage BH; Rubin LJ; Wigley FM; Rich S; Barst RJ; Barrett PS; Kral KM; Jöbsis MM; Loyd JE; Murali S; Frost A; Girgis R; Bourge RC; Ralph DD; Elliott CG; Hill NS; Langleben D; Schilz RJ; McLaughlin VV; Robbins IM; Groves BM; Shapiro S; Medsger TA
Ann Intern Med; 2000 Mar; 132(6):425-34. PubMed ID: 10733441
[TBL] [Abstract][Full Text] [Related]
5. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
6. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.
Humbert M; Sanchez O; Fartoukh M; Jagot JL; Le Gall C; Sitbon O; Parent F; Simonneau G
Eur Respir J; 1999 Jun; 13(6):1351-6. PubMed ID: 10445611
[TBL] [Abstract][Full Text] [Related]
7. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
[TBL] [Abstract][Full Text] [Related]
8. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.
McLaughlin VV; Genthner DE; Panella MM; Hess DM; Rich S
Ann Intern Med; 1999 May; 130(9):740-3. PubMed ID: 10357693
[TBL] [Abstract][Full Text] [Related]
9. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
Sitbon O; Humbert M; Nunes H; Parent F; Garcia G; Hervé P; Rainisio M; Simonneau G
J Am Coll Cardiol; 2002 Aug; 40(4):780-8. PubMed ID: 12204511
[TBL] [Abstract][Full Text] [Related]
10. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
11. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
Galiè N; Humbert M; Vachiéry JL; Vizza CD; Kneussl M; Manes A; Sitbon O; Torbicki A; Delcroix M; Naeije R; Hoeper M; Chaouat A; Morand S; Besse B; Simonneau G;
J Am Coll Cardiol; 2002 May; 39(9):1496-502. PubMed ID: 11985913
[TBL] [Abstract][Full Text] [Related]
12. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
13. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
McLaughlin VV; Genthner DE; Panella MM; Rich S
N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
[TBL] [Abstract][Full Text] [Related]
14. Prostanoids for pulmonary arterial hypertension.
Galiè N; Manes A; Branzi A
Am J Respir Med; 2003; 2(2):123-37. PubMed ID: 14720012
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
Wax D; Garofano R; Barst RJ
Chest; 1999 Oct; 116(4):914-20. PubMed ID: 10531153
[TBL] [Abstract][Full Text] [Related]
16. [Ten years' experience in continuous intravenous epoprostenol therapy in severe pulmonary arterial hypertension].
Pombo Jiménez M; Escribano Subías P; Tello de Meneses R; Gómez-Sánchez MA; Delgado Jiménez J; Dalmau González-Gallarza R; Lázaro Salvador M; Hernández Rodríguez I; Tascón Pérez J; Sáenz de la Calzada C
Rev Esp Cardiol; 2003 Mar; 56(3):230-5. PubMed ID: 12622952
[TBL] [Abstract][Full Text] [Related]
17. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
Steiner MK; Preston IR; Klinger JR; Criner GJ; Waxman AB; Farber HW; Hill NS
Chest; 2006 Nov; 130(5):1471-80. PubMed ID: 17099026
[TBL] [Abstract][Full Text] [Related]
18. [Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic].
Jansa P; Ambroz D; Maresová J; Jelínková L; Polácek P; Palecek T; Aschermann M; Linhart A
Vnitr Lek; 2007 Apr; 53(4):333-7. PubMed ID: 17578162
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral.
Badagliacca R; Pezzuto B; Poscia R; Mancone M; Papa S; Marcon S; Valli G; Sardella G; Ferrante F; Iacoboni C; Parola D; Fedele F; Vizza CD
J Heart Lung Transplant; 2012 Apr; 31(4):364-72. PubMed ID: 22289484
[TBL] [Abstract][Full Text] [Related]
20. One-year experience with intravenous treprostinil for pulmonary arterial hypertension.
Benza RL; Tapson VF; Gomberg-Maitland M; Poms A; Barst RJ; McLaughlin VV
J Heart Lung Transplant; 2013 Sep; 32(9):889-96. PubMed ID: 23953817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
